Insider Stock Trading History of Hoerter Steven L.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Hoerter Steven L. since year 2005. The trader's CIK number is 1533451. At the time of this reporting, Hoerter Steven L. is the Chief Commercial Officer of Agios Pharmaceuticals Inc . (stock ticker symbol AGIO). See this page for all insider trading activities at Agios Pharmaceuticals Inc .

Note that in the past Hoerter Steven L. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Hoerter Steven L. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-05-23 AGIO Agios Pharmaceuticals Inc Option Ex 2,050 39.76 81,508
2018-05-23 AGIO Agios Pharmaceuticals Inc Sale 2,050 85.76 175,808
2018-04-23 AGIO Agios Pharmaceuticals Inc Option Ex 2,050 39.76 81,508
2018-04-23 AGIO Agios Pharmaceuticals Inc Sale 2,050 85.95 176,197
2018-03-22 AGIO Agios Pharmaceuticals Inc Option Ex 2,050 39.76 81,508
2018-03-22 AGIO Agios Pharmaceuticals Inc Sale 2,050 84.65 173,532
2018-02-22 AGIO Agios Pharmaceuticals Inc Option Ex 2,050 39.76 81,508
2018-02-22 AGIO Agios Pharmaceuticals Inc Sale 2,050 78.63 161,191
2018-01-23 AGIO Agios Pharmaceuticals Inc Option Ex 25,000 39.76 994,000
2018-01-23 AGIO Agios Pharmaceuticals Inc Sale 25,000 74.83 1,870,750
2015-03-05 CLVS Clovis Oncology, Inc. Option Ex 20,000 11.02 220,400
2015-03-05 CLVS Clovis Oncology, Inc. Sale 20,000 80.00 1,600,000
2015-02-17 CLVS Clovis Oncology, Inc. Option Ex 10,000 11.02 110,200
2015-02-17 CLVS Clovis Oncology, Inc. Sale 10,000 72.00 720,000
2015-01-16 CLVS Clovis Oncology, Inc. Sale 10,000 67.00 670,000
2015-01-16 CLVS Clovis Oncology, Inc. Option Ex 10,000 11.02 110,200
2015-01-13 CLVS Clovis Oncology, Inc. Option Ex 10,000 11.02 110,200
2015-01-13 CLVS Clovis Oncology, Inc. Sale 10,000 62.00 620,000
2013-06-04 CLVS Clovis Oncology, Inc. Option Ex 10,000 11.02 110,200
2013-06-04 CLVS Clovis Oncology, Inc. Sale 10,000 73.06 730,600

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hoerter Steven L. (Chief Commercial Officer of Agios Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.